Featured Research

from universities, journals, and other organizations

Key DNA Enzyme Can Tolerate More Mutations Than Expected

Date:
May 10, 2000
Source:
University Of Washington
Summary:
A new study from University of Washington researchers shows that a DNA polymerase -- an enzyme -- commonly used for scientific study can tolerate many different mutations and remain functional. The total number of different active mutant forms discovered, 8,000, is apparently the largest library of any polymerase yet known -- and it might be the largest library of any enzyme known.

Many of us saw films in school and think of DNA replication -- the duplication of the cell -- as involving a gliding double-helix that breaks apart and smoothly forms new cells as symphonic music swells in the background. But the latest scientific studies show that cell replication is in fact much different, and far more chaotic. There can be a widespread substitution of different elements of the cell, with all sorts of effects. Those effects can be helpful, as in evolutionary change, or bad, as in cells that run amok and form cancer.

A new study from University of Washington researchers shows that a DNA polymerase -- an enzyme -- commonly used for scientific study can tolerate many different mutations and remain functional. The total number of different active mutant forms discovered, 8,000, is apparently the largest library of any polymerase yet known -- and it might be the largest library of any enzyme known.

"This presents whole paradigms of evolution. The active area of these enzymes is one of the most conserved sites in nature -- that nature has ever created. What this says is that the most conserved site in nature is plastic, within the test tube. You can put in all possible mutations," says the co-author, Dr. Lawrence Loeb. Leob is director of The Joseph Gottstein Memorial Cancer Research Laboratory at the University of Washington School of Medicine and is a professor of pathology and biochemistry and director of UW's Medical Scientist Training Program.

The other co-author is Premal Patel, who carried out the studies. He is a medical scientist training program student, in the M.D./Ph.D. program at the University of Washington.

The findings are being published in the May 9 issue of the journal Proceedings of the National Academy of Sciences.

Polymerases are enzymes -- a type of protein -- that can replicate DNA. DNA forms the genes that give us our characteristics.

The polymerase involved is called Taq, the one most often used by laboratories in polymerase chain reactions (PCR), essential to genetic research and other uses. PCR takes a small amount of DNA, and expands it into a larger amount. That's important because scientists often start with a small amount of DNA, and need a larger quantity for study. So Taq is put into the test tube when medical patients receive genetic tests, or when a forensic scientist studies DNA from a crime scene. Scientists use Taq in their search for, among other things, treatments for cancer and AIDS. Patel inserted random sequences into Taq, and found that many different amino acids would substitute for others. This was different than conventional wisdom, which held that the active site of the polymerase would not tolerate change well.

"Following selection, we found that many different amino acids could be altered without affecting the function dramatically," Patel says. "We think enzymes are highly plastic."

The research may illustrate how bacteria are able to resist antibiotics or other treatment drugs. Because their active site is so mutable, it becomes more likely that the organism may develop a resistance mutation.

Meanwhile, Loeb's laboratory now has a library of 8,000 Taqs that scientists will now scrutinize for other uses. Some of these variations may have uses in biotechnology, Patel says.

Loeb's laboratory has been inserting random sequences into different enzymes for 13 years with the goal of creating gene therapies for cancer. Loeb's laboratory has experimented with inserting random sequences into other parts of the Taq -- not the part that was the subject of the recent paper. That's because that part was the most conserved in nature, and did not on its face appear susceptible to much change.

"We sort of assumed the most conservative site in nature -- all species have it -- would not be mutable, so we avoided it," Loeb says.

Mutations are a key to Loeb's work in cancer experimentation. Twenty-five years ago, Loeb theorized that the engine behind cancer's devastation was a mutator phenotype, in which there is an increasing rate of errors in DNA replication as a tumor grows. Only within the last few years have experiments shown Loeb's theory was correct. His goal now is to find ways to slow the mutation rate. This would not cure cancer, but it would likely extend the lifetimes of most people who get it. The hope, then, would be to eliminate most cancer deaths through delay.

"People tend to think of mutations as constant -- as if you get a certain level a year," Loeb says. "You can manipulate the rates of mutation. In the case of cancer, the goal is to delay the rate of mutation. In the case of Taq, the goal is to increase mutations -- to put mutations in a cell, in the test tube, and then take advantage of the situation."


Story Source:

The above story is based on materials provided by University Of Washington. Note: Materials may be edited for content and length.


Cite This Page:

University Of Washington. "Key DNA Enzyme Can Tolerate More Mutations Than Expected." ScienceDaily. ScienceDaily, 10 May 2000. <www.sciencedaily.com/releases/2000/05/000509003555.htm>.
University Of Washington. (2000, May 10). Key DNA Enzyme Can Tolerate More Mutations Than Expected. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2000/05/000509003555.htm
University Of Washington. "Key DNA Enzyme Can Tolerate More Mutations Than Expected." ScienceDaily. www.sciencedaily.com/releases/2000/05/000509003555.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins